Open Journal Systems

Implantation of permanent pacemakers in Cuenca–Ecuador, from 2017 to 2018

Brigitte Estefanía Secaira Neira, Hermel Medardo Espinosa Espinosa, Lizette Espinosa Martin, Zoila Katherine Salazar Torres, Karla Alexandra Aspiazu Hinostroza, Juan José Solano Noblecilla

Article ID: 1657
Vol 1, Issue 2, 2020

DOI: https://doi.org/10.54517/wt.v1i2.1657
VIEWS - 94 (Abstract)

Abstract

Introduction: In recent years, the placement frequency of permanent pacemakers has increased due to some risk factors, some of which are carried out through cables. Objective: To determine the prevalence and related factors of permanent pacemaker implantation in adult patients in the cardiology department of José Calasco Artega hospital in 2017. Methods: a randomized cross–sectional study was conducted on 422 patients over 18 years old in the cardiology department of “José Carrasco Arteaga” hospital in Cuenca, Ecuador from January to December 2017. Information is processed in SPSS software version 24. Descriptive statistical analysis based on frequency and percentage was used to measure the statistical correlation with odds ratio (or) within 95% confidence interval. When p<0.05, it was considered to be statistically significant. Results: The implantation rate of cardiac pacemaker was 7.1%, and the average age was 65.52 years (DS±14.77), mainly male. The risk factors associated with pacemaker implantation were atrioventricular block or 42.56 (95% confidence interval: 16.06–112.73, p=0.000); Sinoatrial node disease or 59.34 (95% CI: 11.67–301.93, P=0.000) and others or 0.017 (95% confidence interval: 0.00–0.05, p=0.000). Atrial fibrillation was not statistically significant or 1.71 (95% confidence interval: 0.62–4.71, p=0.354). Conclusion: The prevalence of pacemaker implantation is 7.1%, which is related to atrioventricular block, which is the main risk factor, followed by nodular diseases.

Keywords

pacemaker; prevalence; risk factors

Full Text:

PDF

References

1. Ramirez L, Segura L, Chunllo R. Marcapaso unicameral con simulación bicameral: presentación de un caso [Single chamber pacemaker and two chamber simulation: a case report]. Camagui Medical Records 2012; 16(5): 637–643.

2. Khilnani VL, Femenia J,Arce M, et al. Complicaciones del implante de marcapaso definitivo. ¿Unevento operador dependiente? Análisis de 743 pacientes consecutivos [Event related operators?]. Analysis of 743 consecutive inpatients Mexican heart disease archives 2010; 80(2): 95–99.

3. Garc í AE, siles S.Síndrome de Marcapaso en paciente con Síndrome [Patients with pacemaker syndrome]. Journal of Medical Sciences Chinese Academy of Sciences 2012; 16(1): 43–46.

4. Bradyar. Bradiarritmias y bloqueos de la conducción [Rhythmia and conduction block]. Spanish Journal of Cardiology 2012; 65(7): 656–67.

5. Pembo M, Cano O, Lorent D, et al. Resgistro español de marcapasos [Fifteenth report of the cardiac pacing ,Department of the Spanish Society of Cardiology]. Spanish Journal of Heartache2018; 71(15).

6. Izaguirre S. Application of cardiac pacemaker in coronary artery nursing study conducted at Teodoro Maldonado hospital in 2016[Phd Thesis]. Dissertation Guayaquil: School of medicine, University of Guayaquil 2017.

7. Pellegrini C,et al. Predictores de necesidad de marcapasos permanente y alteraciones de la conducción con elimplante transcatéter de una nueva válvula aórtica autoexpandible [Transcatheter implantation of a new self expandable aortic valve predicts permanent pacemaker demand and conduction disorders]. Spanish Journal of Cardiology 2018.

8. Clinical and pacing mode of patients with pacemaker implantation alberto sabogal sologuren hospital in essalud, 2011–2014 [Phd Thesis]. Dissertation Lima, Peru: School of medicine, St. Martin de poles University 2015.

9. Diaz MJP. Depression level and quality of life in patients with pacemaker implantation dissertation quito: School of psychological sciences. [Phd Thesis]. Central University of Ecuador 2015.

10. L ó PEZ, Aguilera J, Segura Saint M, et al.Modificación de la conducción auriculoventricular tras e implante de prótesis aórtica CoreValve[Changes of atrioventricular conduction after aortic valve replacement]. Elsevier, Spanish Journal of Cardiology2016; 69(1): 28–36.

11. Manfredi A, Albornoz H, gambogi R, et al. Seguimiento de marcapasos ycardiodesfibriladores [Follow up of pacemakers and defibrillators]. National Resources Fund 2011; 15(1): 15–22.

12. Férnandez G, Maid GF, Martinez Arias A, et al. Prevalencia de fibrilación auriculary factores predictores de su aparición en pacientes portadores de marcapasos bicamerales [Prevalence and predictors of atrial fibrillation in patients with dual chamber pacemakers]. Elsevier. 2016; 3(86): 214–220.

13. Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. Radiofrequency Ablation as initial therapy inparoxysmal atrial fibrillation [Radiofrequency ablation as an initial treatment for paroxysmal atrial fibrillation]. New England Journal of Medicine 2012; 367(17): 1–9.